Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2000
11/29/2000CN1274719A Process for preparation of substituted pyridine compound
11/29/2000CN1274718A Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same
11/29/2000CN1274711A New intermediate for preparation of anti-histamine piperidine derivatives
11/29/2000CN1274603A Externally-used arthralgia treating medicine and its preparation
11/29/2000CN1274601A Immunity-strengthening and infection-preventing medicine
11/29/2000CN1274586A Burn and scald treating external-use ointment
11/29/2000CN1274582A Oral cesporan with long effect
11/29/2000CN1274581A Application of Alpha-adrenaline receptor blocking agent in preparing medicine for man's sexual dysfunction
11/29/2000CN1274580A Stable delayed vitamin C preparation and its production process
11/29/2000CN1274579A Method for producing particle with hepatoflavin
11/29/2000CN1274578A Preparation of Azithromycin solution and semi-solid
11/29/2000CN1058968C Novel pyrido [3,2-e] pyrazinones with anti-asthmatic action and process for their manufacture
11/29/2000CN1058967C Novel pyridine compounds, processes for their preparation and pharmaceutical compositions thereof
11/29/2000CN1058966C Producing process for crystal of z-oxyethyl -1-[2'-(1H-tetrazole-5-radical) diphenyl-4-(methyl) benzimidazole-7-hydroxy acid 1-(cyclohexyloxy)
11/29/2000CN1058965C New thiophene compounds, process for their preparation and pharmaceutical compositions containing them
11/29/2000CN1058964C Branched-amino-sbustituted thiazoles, process for their preparation and the pharmaceutical compositions which contain them
11/29/2000CN1058962C N4-antipyrinyl-4-hydrxy-3-methoxy cinnamide and producing process thereof
11/29/2000CN1058894C Compound cold-preventing nose drops and their preparation
11/29/2000CN1058880C Compound antibacterial and antiviral veterinary medicine capable of raising immunity
11/29/2000CN1058869C Chinese traditional medicine of hair lotion and preparing process
11/29/2000CN1058866C Medicinal composition for treating tinea manus and pedis
11/29/2000CN1058865C Cream for treating tinea cruris
11/29/2000CA2310174A1 Pyrazolo(3,4-d)(1,2,3)triazines having anticonvulsant activity and processes for their preparation
11/28/2000US6153774 Silver ion chromatography of high purity conjugated linoleic acid (CLA)
11/28/2000US6153768 Benzopyran derivatives
11/28/2000US6153754 Process for production of piperidine derivatives
11/28/2000US6153751 Preparing the antiviral b-isomer of a 1,3-oxathiolane nucleoside by reacting in presence of stannic chloride
11/28/2000US6153736 Modified ether glyceroglycolipids
11/28/2000US6153731 Dehydrodidemnin B
11/28/2000US6153654 Method of improving outcome of cardiopulmonary bypass surgery
11/28/2000US6153653 Choline compositions and uses thereof
11/28/2000US6153652 N-(aryl/heteroaryl/alkylacetyl) amino acid amides, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
11/28/2000US6153651 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/28/2000US6153650 Treatment of epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, inflammation, and gastrointestinal damage.
11/28/2000US6153649 Use of carboxylic acids having a sulphur function for promoting skin exfoliation or stimulating epidermal regeneration
11/28/2000US6153647 Method for augmenting the inotropic effects of β-adrenergic agonists using pyruvate therapy
11/28/2000US6153646 Binuclear platinum complexes, method for preparing same and pharmaceutical compositions containing said complexes
11/28/2000US6153644 Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
11/28/2000US6153643 Anti-cancer-substance
11/28/2000US6153642 Useful as antineoplastic and antiviral agents
11/28/2000US6153640 For treating depression, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse or anxiety
11/28/2000US6153639 Treatment of tumors by irradiating with light after administration of protoporphyrin derivative
11/28/2000US6153638 Administering efaroxan or its salt in racemic form or in the form of an optically-active isomer for treating huntington's disease
11/28/2000US6153635 Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate
11/28/2000US6153631 Treating condition in vertebrate animal characterized by a deficiency in, or need for, bone growth replacement and/or an undesirable level of bone resorption, by administering to benzothiazole derivative
11/28/2000US6153630 Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same
11/28/2000US6153628 1,3,4-thiadiazoles and 1,3,4-Oxadiazoles as αv β3 antagonists
11/28/2000US6153626 For treating pain, gastrointestinal disorders, spinal cord injury
11/28/2000US6153625 For treatment of disorders in which involvement of serotoninergic system has been demonstrated, as in psychiartic disorders such as depression, anxiety, panic attack, schizophrenia, aggression, impulsive disorders
11/28/2000US6153624 Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders
11/28/2000US6153623 Cisapride extended release
11/28/2000US6153622 Estrogen agonists/antagonists
11/28/2000US6153621 Combined antagonist compositions
11/28/2000US6153620 Opiate receptor antagonist modulates movement disorder
11/28/2000US6153615 Administering nitric oxide synthesis inhibiting amount of dihydrofolate reductase inhibitor, catecholamine replacing non-toxic amount of levodopa with or without carbidopa and serotonin replacing non-toxic amount of l-5-hydroxytryptophane
11/28/2000US6153614 Piperazinyl pyrimidine dione compounds selective for adrenoceptors
11/28/2000US6153611 As non-dopaminergic antiischemic compounds for treating brain disorders
11/28/2000US6153610 For treating cancer tumors
11/28/2000US6153609 Arylsulfonylamino hydroxamic acid derivatives
11/28/2000US6153608 Isoquinoline derivatives and drugs
11/28/2000US6153607 Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance (or turnover)
11/28/2000US6153606 Memory enhancement by the administration of Δ5-androstene-3β-ol-7,17-dione and 3β esters thereof
11/28/2000US6153605 Useful in treatment or prevention of vitamin d dependent disorders, particularly psoriasis, basal cell carcinomas, disorders of keratinization and keratosis, leukemia, osteoporosis, hyperparathyroidism accompanying renal failure
11/28/2000US6153604 Treating disease of nervous system in which pathophysiology of disorder involves excessive excitation of nerve cells by agonists of nmda receptors, comprising administering to guanidine derivative
11/28/2000US6153603 Method of treating angiogenesis in tumor tissue
11/28/2000US6153601 Polyholoside compositions for stimulating the immune system
11/28/2000US6153598 Acts as synthetic vector for achieving efficient transfection of associated nucleic acid into a cell; gene therapy
11/28/2000US6153597 For gene therapy such as in vitro, ex vivo and/or in vivo transfer of genetic material
11/28/2000US6153595 Composition and method for treatment of CMV infections
11/28/2000US6153594 5'-O-acylated antiviral nucleosides
11/28/2000US6153589 2,3-epoxy alcohols, acids and derivatives as anti retroviral chemotherapeutic agents
11/28/2000US6153433 Suppressing microorganismal propagation; insertion of nucleotide sequences coding viricidal polypeptide into cells infected with hepatitis viral agent, monitor for propagation
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153396 Drug screening by adding compound to mixture of chaperone and pilus subunit and determining the change in binding; bactericides for urinary tract infections
11/28/2000US6153242 Method for preparing snack food
11/28/2000US6153225 Injectable formulations of nanoparticulate naproxen
11/28/2000US6153220 Taste-masked formulations
11/28/2000US6153217 Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents
11/28/2000US6153216 Transdermal estradiol/progestogen agent patch and its production
11/28/2000US6153207 Anti-cellulite pantyhose
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000US6153193 Compositions for targeting biological agents
11/28/2000US6153186 Red blood cells loaded with S-nitrosothiol and uses therefor
11/28/2000US6153180 Agent and method for permanently shaping the hair, based on n-branched-chain alkyl-substituted mercapto acetamides and process for their preparation
11/28/2000US6153171 Methods for identifying compounds effective for treating neurodegenerative disorders and for monitoring the therapeutic intervention therefor
11/28/2000US6153129 Production scale method of forming microparticles
11/28/2000US6152926 Spine distraction implant and method
11/28/2000CA2309520A1 Compositions for stabilizing oxygen-labile species
11/28/2000CA2309505A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309475A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309434A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/28/2000CA2309375A1 Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for steroid
11/28/2000CA2307357A1 Wbpp and method for assay of wbpp
11/28/2000CA2300452C Orally administrable solid ribavirin dosage forms and process for making them
11/28/2000CA2267136C Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/28/2000CA2254506C Piperidine derivatives and process for their production
11/28/2000CA2200795C Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general
11/28/2000CA2192820C Pyrazolo and pyrrolopyridines
11/28/2000CA2182970C Lyophilized stem cell factor formulations
11/28/2000CA2182575C Oil-in-water emulsions